GenVec Highlights Gorilla Adenovectors At Vaccines R&D-2015 Conference
GAITHERSBURG, Md., Nov. 4, 2015 /PRNewswire/ — GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced that Douglas E. Brough, Ph.D., the company’s chief scientific…
